Lipoarabinomannan in urine during tuberculosis treatment: Association with host and pathogen factors and mycobacteriuria

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Wood, Robin ^a,b   Racow, Kimberly ^a   Bekker, Linda Gail ^a   Middelkoop, Keren ^a   Vogt, Monica ^a   Kreiswirth, Barry N ^c   Lawn, Stephen D ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LIPOARABINOMANNAN; RIFAMPICIN; BACTERIAL ANTIGEN; BACTERIAL DNA; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIURIA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID ANALYSIS; LIPOARABINOMANNAN URINE LEVEL; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIURIA; NONHUMAN; PROSPECTIVE STUDY; PROTEINURIA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTH AFRICA; SPUTUM SMEAR; TREATMENT OUTCOME; TUBERCULOSIS; URINALYSIS; URINE LEVEL; CHEMISTRY; CLASSIFICATION; DNA FINGERPRINTING; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; SPUTUM; TRANSPOSON; URINE;

ADULT; ANTIGENS, BACTERIAL; BACTERIURIA; DNA FINGERPRINTING; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SOUTH AFRICA; SPUTUM; TUBERCULOSIS; URINE;

EID: 84857406233     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-47     Document Type: Article

References (39)

1. Hunter SW, Gaylord H, Brennan PJ. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem 1986, 261(26):12345-12351.
2. Pitarque S, Larrouy-Maumus G, Payré B, Jackson M, Puzo G, Nigou J. The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface. Tuberculosis (Edinb) 2008, 88(6):560-565.
3. Mishra AK, Driessen NN, Appelmelk BJ, Besra GS. Lipoarabinomannan and related glycol-conjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol Rev 2011, doi:10.1111/j.15746976.2011.00276.x.
4. Murase T, Zheng RB, Joe M, Bai Y, Marcus SL, Lowary TL, Ng KKS. Structural insights into antibody recognition of mycobacterial polysaccharides. J Mol Biol 2009, 392:381-392. 10.1016/j.jmb.2009.06.074, 19577573.
5. Eleftheriadis T, Tsiaga P, Antoniadi G, Liakopoulos V, Kortsaris A, Giannatos E, Barbutis K, Stefanidis I, Vargemezis V. The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients. Am J Kidney Dis 2005, 46(4):706-712. 10.1053/j.ajkd.2005.06.021, 16183426.
6. Tessema TA, Bjune G, Hamasur B, Svenson S, Syre H, Bjorvatn B. Circulating antibodies to lipoarabinomannan in relation to sputum microscopy, clinical features and urinary anti- lipoarabinomannan detection in pulmonary tuberculosis. Scand J Infect Dis 2002, 34(2):97-103. 10.1080/00365540110077263, 11928861.
7. Ludwiczak P, Gilleron M, Bordat Y, Martin C, Gicquel B, Puzo G. Mycobacterium tuberculosis pho mutant lipoarabinomannan molecular structure. Microbiology 2002, 148(10):3029-3037.
8. Sada E, Aguilar D, Torres M, Herrera T. Detection of lipoarabinomannan as a diagnostic test for tuberculosis. J Clin Micro 1992, 30(9):2415-2418.
9. Pereira Arias-Bouda LM, Nguyen LN, Ho LM, Kuijper S, Jansen HM, Kolk AH. Development of antigen detection assay for diagnosis of tuberculosis using sputum samples. J Clin Micro 2000, 38:2278-2283.
10. Dheda K, Davids V, Lenders L, et al. Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples. PLoS One 2010, 5(3):e9848. 10.1371/journal.pone.0009848, 2844421, 20352098.
11. Hamasur B, Bruchfeld J, Haile M, Pawlowski A, Bjorvatn B, Kallenius G, et al. Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods 2001, 45:41-52. 10.1016/S0167-7012(01)00239-1, 11295196.
12. Tessema TA, Hamasur B, Bjun G, Svenson S, Bjorvatn B. Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. Scand J Infect Dis 2001, 33:279-284. 10.1080/003655401300077306, 11345220.
13. Tessema TA, Bjune G, Assefa G, Svenson S, Hamasur B, Bjorvatn B. Clinical and radiological features in relation to urinary excretion of lipoarabinomannan in Ethiopian tuberculosis patients. Scand J Infect Dis 2002, 34:167-171. 10.1080/00365540110077254, 12030387.
14. Boehme C, Molokova E, Minja F, Geis S, Loscher T, Maboko L, et al. Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. Trans R Soc Trop Med Hyg 2005, 99:893-900. 10.1016/j.trstmh.2005.04.014, 16139316.
15. Daley P, Michael JS, Hmar P, et al. Blinded evaluation of commercial urinary lipoarabinomannan for active tuberculosis: a pilot study. Int J Tuberc Lung Dis 2009, 13:989-995. 2951988, 19723379.
16. Mutetwa R, Boehme C, Dimairo M, et al. Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. Int J Tuberc Lung Dis 2009, 13:1253-1259.
17. Lawn SD, Edwards DJ, Kranzer K, Vogt M, Bekker L-G, Wood R. Urine lipoarabinomannan assay for tuberculosis screening before antiretroviral therapy: diagnostic yield and association with immune reconstitution disease. AIDS 2009, 23:1875-1880. 10.1097/QAD.0b013e32832e05c8, 20108382.
18. Shah M, Martinson NA, Chaisson RE, Martin DJ, Variava ME, Dorman S. Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis. J Clin Microbiol 2010, 48:2972-2974. 10.1128/JCM.00363-10, 2916614, 20534796.
19. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA. Diagnostic accuracy of urine lipoaribinomannan test for tuberculosis in hospitalised patients in a high prevalence setting. J Acquir Immune Defic Synd 2009, 52(2):145-51.
20. Pai M, Minion J, Sohn H, Zwerling A, Perkins MD. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med 2009, 30:701-716. 10.1016/j.ccm.2009.08.016, 19925962.
21. Minion J, Leung E, Talbot E, Dheda K, Pai M, Menzies D. Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta- analysis. Eur Respir J 2011, doi:10.1183/09031936.00025711.
22. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Screening for HIV-associated tuberculosis prior to antiretroviral therapy: diagnostic accuracy of a low-cost, urine antigen, point-of-care assay (Determine TB-LAM). Lancet Infect Dis 2011,
23. Schwebach JR, Casadevall A, Schneerson R, Dai Z, Wang X, Robbins JB, Glatman-Freedman A. Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infect Immun 2001, 69:5671-5678. 10.1128/IAI.69.9.5671-5678.2001, 98683, 11500443.
24. Neyrolles O, Guilhot C. Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesis. Tuberculosis (Edinb) 2011, 91(3):187-95.
25. Ordway GA, Garyry DJ. Myoglobin: an essential hemoprotein in striated muscle. J Exp Med 2004, 207(20):3441-6.
26. Roberts-Thomson PJ, Shepherd K. Molecular size and heterogeneity of immunoglubulins in health and disease. Clin exp Immunol 1990, 79:328-334. 1534949, 2317941.
27. Harraldson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008, 88:451-487. 10.1152/physrev.00055.2006, 18391170.
28. Donald PR, Diacon AH. The early bactericidal activity of anti-tuberculosis drugs: a literature review. Tuberculosis (Edinb) 2008, 88(Suppl 1):S75-83.
29. Middelkoop K, Bekker L-G, Myer L, Johnson LF, Kloos M, Morrow C, Wood R. Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. J Acquir Immune Defic Synd 2011, 53(3):263-269.
30. The South African Tuberculosis Control Programme Practical Guidelines South African Department of Health; 2000. [http://www.capegateway.gov.za/Text/2003/tb_guidelines2000.pdf] Accessed 23 July 2011, The South African Tuberculosis Control Programme Practical Guidelines.
31. Hilleman D, Ruesch-Gerdes S, Boehme C, Richter E. Rapid molecular detection of extrapulmonary tuberculosis by automated GeneXpert® MTB/RIF system. J Clin Micro 2011, 49(4):1202-1205.
32. Gaspari F, Perico N, Remuzzi G. Timed urine collections are not needed to measure urine protein excretion in clinical practice. Am J Kidney Dis 2006, 47(1):1-7. 10.1053/j.ajkd.2005.10.014, 16377379.
33. van Embden JD, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993, 31:406-409. 262774, 8381814.
34. Bifani PJ, Mathema B, Liu Z, et al. Identification of a W variant out- break of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 1999, 282:2321-2327. 10.1001/jama.282.24.2321, 10612319.
35. Middelkoop K, Bekker L-G, Mathema B, Shashkina E, Kurepina N, Whitelaw A, Morrow C, Kreiswirth B, Kaplan G, Wood R. Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J Infect Dis 2009, 200(8):1207-1211. 10.1086/605930, 2932637, 19764885.
36. Middelkoop K, Mathema B, Myer L, Shashkina E, Kreisworth B, Kurepina N, Wood R, Bekker L-G. Transmission of TB in a High HIV-Prevalent South African Community [TUPE163] 2011, Rome: Abstracts of the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention.
37. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 2006, 19:658-685. 10.1128/CMR.00061-05, 1592690, 17041139.
38. Lawn SD, Nicol MP. Xpert MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Micro 2011,
39. Lawn SD, Wood R. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 2011,